QTc interval in infants receiving cisapride

Journal of Perinatology

Volumn 22, Issue 2, 2002, Pages 144-148

  Chhina, Satbir ^a   Peverini, Ricardo L ^b   Deming, Douglas D ^b   Hopper, Andrew O ^b   Hashmi, Aijaz ^b   Vyhmeister, Nidia R ^b  

^a Doctors Hospital of Laredo   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAM; GASTROINTESTINAL MOTILITY; HEART ARRHYTHMIA; HUMAN; INFANT; LONG QT SYNDROME; NEWBORN; PATIENT MONITORING; PROSPECTIVE STUDY; QT INTERVAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; CISAPRIDE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; ESOPHAGEAL MOTILITY DISORDERS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL MOTILITY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 85047698680     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210613     Document Type: Article

References (32)

1. Cisapride decreases gastroesophageal reflux in preterm infants
2. Cisapride reduces neonatal postoperative ileus: Randomised placebo controlled trial
3. Advances in the diagnosis and treatment of gastroesophageal reflux disease
4. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: A report from a working group on gastrooesophageal reflux disease
5. Current concepts and issues in the management of regurgitation of infants: A reappraisal. Management guidelines from a working party
6. Cisapride therapy for gastrointestinal disease
7. Development of gastrointestinal structure and function
8. Gastrointestinal motility in the neonate
9. Randomised controlled trial of cisapride in feed intolerance in preterm infants
10. Gastric emptying in infants with gastroesophageal reflux. Ultrasound evaluation before and after cisapride administration
11. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease
12. Cisapride: A gastrointestinal prokinetic drug
13. Response of premature infants with prolonged feeding intolerance to cisapride
14. Cisapride and fatal arrhythmia
15. Long QT syndrome during high-dose cisapride
16. Proarrhythmia associated with cisapride in children
17. Effects of cisapride on QTc interval in neonates
18. Effects of cisapride on QT interval in children
19. Cisapride-induced long QT interval
20. QT interval in children and infants receiving cisapride
21. Cisapride: A survey of the frequency of use and adverse events in premature newborns
22. Tachycardia during cisapride treatment
23. QTc measurements in genotyped children with long QT syndrome
24. The use of cisapride in children
25. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors
26. The role of cisapride in the treatment of pediatric gastroesophageal reflux
27. An analysis of the time relations of the electrocardiograms
28. Prolonged QT interval in neonates: Benign, transient, or prolonged risk of sudden death
29. The QT interval throughout the first 6 months of life: A prospective study
30. Effects of cisapride on corrected QT interval, heart rate, and rhythm in infants undergoing polysomnography
31. Cisapride associated with QTc prolongation in very low birth weight preterm infants
32. Evaluation of cisapride as a pharmacologic probe for CYP3A4